-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Keros Therapeutics, Inc. annual/quarterly Operating Lease, Payments history and growth rate from Q1 2022 to Q1 2023.
- Keros Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2023 was $500K, a 150% increase year-over-year.
- Keros Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $1.12M, a 22.9% increase from 2022.
- Keros Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $913K, a 55.5% increase from 2021.
- Keros Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $587K, a 25.4% increase from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)